# u-STOP LVAD Bleed: Utilization of Umbilical Cord Lining Stem Cells (ULSCs) To Prevent Left Ventricular Assist Device (LVAD) Associated Angiodysplastic Bleeding

> **NCT04811261** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Florida** · enrollment: 9 (actual)

## Conditions studied

- Angiodysplastic Bleeding

## Interventions

- **DRUG:** Intravenous Infusion of UCLSCs

## Key facts

- **NCT ID:** NCT04811261
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-01
- **Primary completion:** 2023-07-27
- **Final completion:** 2023-07-27
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04811261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04811261, "u-STOP LVAD Bleed: Utilization of Umbilical Cord Lining Stem Cells (ULSCs) To Prevent Left Ventricular Assist Device (LVAD) Associated Angiodysplastic Bleeding". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04811261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*